» Articles » PMID: 34427956

Recurrent NF1 Gene Variants and Their Genotype/phenotype Correlations in Patients with Neurofibromatosis Type I

Abstract

Neurofibromatosis type I, a genetic condition due to pathogenic variants in the NF1 gene, is burdened by a high rate of complications, including neoplasms, which increase morbidity and mortality for the disease. We retrospectively re-evaluated the NF1 gene variants found in the period 2000-2019 and we studied for genotype/phenotype correlations of disease complications and neoplasms 34 variants, which were shared by at least two unrelated families (range 2-11) for a total 141 of probands and 21 relatives affected by Neurofibromatosis type I. Recurrent variants could be ascribed to the most common mutational mechanisms (C to T transition, microsatellite slippage, non-homologous recombination). In genotype/phenotype correlations, the variants p.Arg440*, p.Tyr489Cys, and p.Arg1947*, together with the gross gene deletions, displayed the highest rates of complications. When considering neoplasms, carriers of variants falling in the extradomain region at the 5' end of NF1 had a lower age-related cancer frequency than the rest of the gene sequence, showing a borderline significance (p = 0.045), which was not conserved after correction with covariates. We conclude that (1) hotspots in NF1 occur via different mutational mechanisms, (2) several variants are associated with high rates of complications and cancers, and (3) there is an initial evidence toward a lower cancer risk for carriers of variants in the 5' end of the NF1 gene although not significant at the multivariate analysis.

Citing Articles

Genotypes and phenotypes of neurofibromatosis type 1 patients in Japan: A Hereditary Tumor Cohort Study.

Futagawa M, Okazaki T, Nakata E, Fukano C, Osumi R, Kato F Hum Genome Var. 2024; 11(1):42.

PMID: 39592598 PMC: 11599849. DOI: 10.1038/s41439-024-00299-4.


The genetic spectrum of variants in 10 unrelated Chinese families with neurofibromatosis type 1.

Chen S, Cheng H, Zhao G Neurosciences (Riyadh). 2024; 29(3):177-183.

PMID: 38981629 PMC: 11305348. DOI: 10.17712/nsj.2024.3.20230003.


Mutation analysis and clinical profile of South African patients with Neurofibromatosis type 1 (NF1) phenotype.

Mudau M, Dillon B, Smal C, Feben C, Honey E, Carstens N Front Genet. 2024; 15:1331278.

PMID: 38596211 PMC: 11002079. DOI: 10.3389/fgene.2024.1331278.


Schwann cells modulate nociception in neurofibromatosis 1.

Raut N, Maile L, Oswalt L, Mitxelena I, Adlakha A, Sprague K JCI Insight. 2024; 9(2).

PMID: 38258905 PMC: 10906222. DOI: 10.1172/jci.insight.171275.


Germline Variants in Cancer Predisposition Genes in Pediatric Patients with Central Nervous System Tumors.

Jovanovic A, Tosic N, Marjanovic I, Komazec J, Zukic B, Nikitovic M Int J Mol Sci. 2023; 24(24).

PMID: 38139220 PMC: 10744041. DOI: 10.3390/ijms242417387.


References
1.
Maher G, Ralph H, Ding Z, Koelling N, Mlcochova H, Giannoulatou E . Selfish mutations dysregulating RAS-MAPK signaling are pervasive in aged human testes. Genome Res. 2018; 28(12):1779-1790. PMC: 6280762. DOI: 10.1101/gr.239186.118. View

2.
Uusitalo E, Rantanen M, Kallionpaa R, Poyhonen M, Leppavirta J, Yla-Outinen H . Distinctive Cancer Associations in Patients With Neurofibromatosis Type 1. J Clin Oncol. 2016; 34(17):1978-86. DOI: 10.1200/JCO.2015.65.3576. View

3.
Samocha K, Robinson E, Sanders S, Stevens C, Sabo A, McGrath L . A framework for the interpretation of de novo mutation in human disease. Nat Genet. 2014; 46(9):944-50. PMC: 4222185. DOI: 10.1038/ng.3050. View

4.
Pasmant E, Sabbagh A, Spurlock G, Laurendeau I, Grillo E, Hamel M . NF1 microdeletions in neurofibromatosis type 1: from genotype to phenotype. Hum Mutat. 2010; 31(6):E1506-18. DOI: 10.1002/humu.21271. View

5.
Koczkowska M, Callens T, Chen Y, Gomes A, Hicks A, Sharp A . Clinical spectrum of individuals with pathogenic NF1 missense variants affecting p.Met1149, p.Arg1276, and p.Lys1423: genotype-phenotype study in neurofibromatosis type 1. Hum Mutat. 2019; 41(1):299-315. PMC: 6973139. DOI: 10.1002/humu.23929. View